BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27059987)

  • 21. Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database.
    Leuzzi G; Rocco G; Ruffini E; Sperduti I; Detterbeck F; Weder W; Venuta F; Van Raemdonck D; Thomas P; Facciolo F;
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):47-57.e1. PubMed ID: 26403869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
    Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
    Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
    Tsavaris N; Kosmas C; Papadoniou N; Kopterides P; Tsigritis K; Dokou A; Sarantonis J; Skopelitis H; Tzivras M; Gennatas K; Polyzos A; Papastratis G; Karatzas G; Papalambros A
    J Chemother; 2009 Dec; 21(6):673-80. PubMed ID: 20071292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the use of pre-operative radiation for adenocarcinoma of the pancreas in the United States.
    Burke EE; Marmor S; Portschy PR; Virnig BA; Cho LC; Tuttle TM; Jensen EH
    HPB (Oxford); 2015 Jun; 17(6):542-50. PubMed ID: 25726950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.
    Torgeson A; Lloyd S; Boothe D; Tao R; Whisenant J; Garrido-Laguna I; Cannon GM
    Cancer; 2017 Oct; 123(19):3816-3824. PubMed ID: 28621885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer.
    Wells SM; Boothe D; Ager BJ; Tao R; Gilcrease GW; Lloyd S
    Clin Colorectal Cancer; 2020 Jun; 19(2):91-99.e1. PubMed ID: 32173281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.
    de Geus SWL; Eskander MF; Kasumova GG; Ng SC; Kent TS; Mancias JD; Callery MP; Mahadevan A; Tseng JF
    Cancer; 2017 Nov; 123(21):4158-4167. PubMed ID: 28708929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.
    Chen Q; Ning Z; Wang L; Ying H; Dong S; Zhang C; Shen X; Guo Y; Chen H; Zhu X; Shen Y; Shi W; Hua Y; Wang K; Lin J; Xu L; Chen L; Feng L; Zhang X; Xie J; Sun B; Sun Y; Gu W; Kang M; Tang Z; Chen Z; Chen Z; Liu L; Yu J; Li Z; Meng Z
    Oncotarget; 2016 Dec; 7(51):85603-85612. PubMed ID: 27811354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
    Ma SJ; Iovoli AJ; Hermann GM; Prezzano KM; Singh AK
    Cancer Med; 2019 Aug; 8(9):4110-4123. PubMed ID: 31183965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival: A SEER Database Analysis.
    Sajjad M; Batra S; Hoffe S; Kim R; Springett G; Mahipal A
    Am J Clin Oncol; 2018 Mar; 41(3):236-241. PubMed ID: 26796313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locally advanced pancreatic cancer: the role of definitive chemoradiotherapy.
    Huguet F; Mukherjee S; Javle M
    Clin Oncol (R Coll Radiol); 2014 Sep; 26(9):560-8. PubMed ID: 25001636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
    Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
    Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
    Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
    J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of Care for Locally Advanced Pancreatic Adenocarcinoma Using the National Cancer Database.
    Amini A; Jones BL; Stumpf P; Leong S; Lieu CH; Weekes C; Davis SL; Messersmith WA; Purcell WT; Ghosh D; Schefter T; Goodman KA
    Pancreas; 2017 Aug; 46(7):904-912. PubMed ID: 28697131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
    Ikeda M; Ioka T; Ito Y; Yonemoto N; Nagase M; Yamao K; Miyakawa H; Ishii H; Furuse J; Sato K; Sato T; Okusaka T
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):163-9. PubMed ID: 22677367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy.
    Liu P; Zhu Y; Liu L
    Oncotarget; 2015 Apr; 6(11):9592-9. PubMed ID: 25860937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.
    Yu WD; Peng YF; Pan HD; Wang L; Li K; Gu J
    World J Gastroenterol; 2014 Nov; 20(43):16258-67. PubMed ID: 25473181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.